Dear Editor, The first case of Takayasu’s arteritis (TA) was described in 1908 by Dr. Mikito Takayasu [1] at the Annual Meeting of the Japan Ophthalmology Society. Dr. Takayasu described a peculiar “wreathlike” appearance of blood vessels in the back of the eye (retina). Two Japanese colleagues at the same meeting reported similar eye findings in patients whose wrist pulses were absent. It is now known that TA is a large-vessel vasculitis of unknown etiology that has a predilection for the aorta and its primary branches Figs. 1 and 2. TA has traditionally been divided into an early, “prepulseless” systemic phase and a late occlusive phase. In the early systemic phase, diagnosis is difficult and symptoms are usually nonspecific and constitutional, including fever, myalgias, weight loss, and arthralgias. In the occlusive phase, ischemic symptoms dominate, including angina, claudication, syncope, and visual impairment. Late-phase TA may be further subclassified as classic pulseless disease (type 1), a mixed type (type 2), an atypical coarctation type (type 3), and a dilated type (type 4). The clinical presentation of TA and the results of laboratory tests at the onset of the disease are typically nonspecific, which may lead to delayed diagnosis and most of the patients present with the late-phase disease. Accurate diagnosis virtually always depends on imaging studies; nevertheless, angiography is an invasive method that carries well-known risks of complications resulting from the procedure itself, such as hematoma, arteriovenous fistula, pseudoaneurysm, and vessel thrombosis. The reported overall prevalence of a major vascular complication is 0.02–9% [2]. Magnetic resonance angiography (MRA) advantages include the lack of the need for ionizing radiation and iodinated contrast material; therefore, MRA is ideal for serial evaluation of patients with TA who are undergoing treatment. Furthermore, MRA provides the ability to view vessels in any desired plane, and techniques like cine magnetic resonance imaging (MRI) can detect cardiovascular functional and hemodynamic changes, such as aortic regurgitation, in patients with TA. As with the CT scan, MRI is useful for early diagnosis because of its ability to evaluate wall thickness rather than just the luminal narrowing. In addition, MRA provides detailed information about the location, extent, and degree of vascular involvement. It also provides detailed information about the extent of stenotic lesions, the patency of collateral vessels, and it also seems useful as a follow-up modality to assess the response to treatment [3]. Given the fact that in clinical practice, some patients with TA show normal Erythrocyte sedimentation rate (ESR) at their initial evaluation, and this may give false impression that they Clin Rheumatol (2007) 26:1393–1395 DOI 10.1007/s10067-007-0577-2
Read full abstract